Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Endocrinology
Disease Category: Obesity

Trial Information

A study on how weight loss surgery causes low sugar levels after meals

This study is investigating the major factors that control blood glucose (sugar), including GLP-1, which is a hormone released from the intestine after meals, and increases insulin secretion. Insulin is the main hormone that controls the level of glucose in the blood.

Participants will be asked to visit the clinical research center at the Cincinnati Children's Hospital or the VA Medical Center up to 4 sessions for a period of 1-2 months. Each session may take up to 5 hours, for which the participant will be compensated.

Patient Inclusion Criteria:

Age 18 and older

Men and women who have had gastric bypass surgery

Must suffer from any of the following symptoms without taking any medications for diabetes: severe hunger, nervousness and shakiness, perspiration, dizziness or light-headedness, sleepiness, confusion, difficulty speaking, or feeling anxious or weak

Patient Exclusion Criteria:

• Currently taking medications for diabetes

Marzieh Salehi, M.D., Assistant Professor of Medicine
University of Cincinnati
College of Medicine
Division of Endocrinology, Diabetes and Metabolism
3125 Eden Avenue, ML 0547
Cincinnati, OH 45267-0547
Phone: 513-558-4444
Fax: 513-558-8581
EMail: marzieh.salehi@uc.edu

View Google Map

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.